Comments
Loading...
Verrica Pharmaceuticals (VRCA) Forecast
NewsEarningsVerrica Pharmaceuticals (VRCA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVerrica Pharmaceuticals (NASDAQ:VRCA) Stock Quotes, Forecast and News Summary
Verrica Pharmaceuticals Stock (NASDAQ: VRCA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Verrica Pharmaceuticals (VRCA) stock?
You can purchase shares of Verrica Pharmaceuticals (NASDAQ:VRCA) through any online brokerage.
Who are Verrica Pharmaceuticals (VRCA) competitors?
Other companies in Verrica Pharmaceuticals’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Rani Therapeutics Hldgs (NASDAQ:RANI).
What is the forecast, or price target, for Verrica Pharmaceuticals (VRCA) stock?
Verrica Pharmaceuticals has a consensus price target of $6.80.
What is the current price for Verrica Pharmaceuticals (VRCA)?
The stock price for Verrica Pharmaceuticals (NASDAQ: VRCA) is $0.6197 last updated December 19, 2024 at 10:56 AM EST.
Does Verrica Pharmaceuticals (VRCA) pay a dividend?
There are no upcoming dividends for Verrica Pharmaceuticals.
When is Verrica Pharmaceuticals (NASDAQ:VRCA) reporting earnings?
Verrica Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 27, 2025.
Is Verrica Pharmaceuticals (VRCA) going to split?
There is no upcoming split for Verrica Pharmaceuticals.
What sector and industry does Verrica Pharmaceuticals (VRCA) operate in?
Verrica Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.